biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > We're tied, poof! Lookie dat!

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Jan 16, 2023 8:52pm

95 Views

Post# 35226923

RE:We're tied, poof! Lookie dat!

I'm not into likes. The market is about sometimes being the only one with an opinion and that can get you into a lot of trouble on message boards because stocks for many are sacred cows. They can be a religion. The independent mind is the sacred mind in investing.

<< Previous

Bullboard Posts

Next >>

Gold Flora's Gramlin holds court in California cannabis market